Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapy - Reid Shaw; James J. Yoon; Hannah Johnston; Marta B. Davidson; Alexa J. Siddon; Rory M. Shallis; Evan C. Chen; Madelyn Burkart; Timothy S. Oh; Sunil G. Iyer; Ellen Madarang; Chandrasekar Muthiah; et al. (Blood Advances)